by Microbiologics | Jan 5, 2026 | CRO Laboratory Services, Pharmaceutical, Uncategorized
Live Biotherapeutic Products (LBPs) are drug products designed to prevent, treat, or cure disease using living microorganisms. These therapeutics present unique challenges for quality control, especially in the development of microbial safety methods. This blog post...
by Microbiologics | Dec 16, 2025 | CRO Laboratory Services
In vaccine and antiviral development, confidence in viral identity and genome integrity is essential. Whether confirming strain authenticity, validating genetic modifications, or identifying spontaneous mutations, genomics analyses ensure that research materials align...
by Olivia Walser | Sep 26, 2025 | CRO Laboratory Services
They outnumber your human cells. They influence everything from digestion to immunity. And now, microbes are reshaping how we understand and treat disease. The microbiome, the vast community of microorganisms living in and on our bodies, plays a crucial role in...
by Microbiologics | Aug 21, 2025 | CRO Laboratory Services
In the world of vaccine and antiviral development, access to high-quality, reliable viral reference materials can make or break a research program. Yet, few outside the industry understand how these critical reagents are manufactured, or by whom. When most people...
by Microbiologics | Jun 12, 2025 | CRO Laboratory Services, Pharmaceutical
Adventitious agent testing is critical to ensure patient safety and maintain product integrity. Biopharmaceuticals, often derived from living cells, are susceptible to contamination by viruses and mycoplasmas, which can be introduced during cell culture, raw material...
by Andrea Marra | Jul 26, 2023 | Clinical, CRO Laboratory Services, Molecular, Pharmaceutical
At any given time, one in five people in the US has a sexually transmitted infection (STI), translating to more than 60 million infections per year.1 These infections cost billions in healthcare expenses each year. Even more alarming, over 40% of all new STIs in this...
